Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation
Launched by CREIGHTON UNIVERSITY · Dec 10, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help improve balance and reduce dizziness in people with a condition called bilateral vestibular hypofunction (BVH). BVH affects the inner ear, which is responsible for balance, and it can make everyday activities challenging. Symptoms include feeling off-balance, having a wobbly vision when moving your head, and a higher risk of falling. The trial aims to see if a technique called subthreshold vestibular stimulation—using gentle movements—can enhance the effectiveness of balance training for individuals with BVH.
To participate, you need to be an adult who has experienced symptoms for at least three months, such as unsteadiness while walking or standing. You should also be able to stand without assistance and weigh no more than 300 pounds. People with certain medical conditions, severe injuries, or who are pregnant cannot take part in the study. If you join, you can expect to receive specialized balance training combined with this new stimulation method, which may help improve your balance and overall quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilateral yaw aVOR gain of \< 0.8 on video head impulse testing OR bilateral positive bedside head impulse test
- • Symptoms of at least 3-month duration that include (a) Unsteadiness with walking or standing, (b) Either oscillopsia or worsened balance on uneven ground or with vision removed, and (c) No symptoms sitting or lying down.
- • Must be able to stand
- • No leg or foot amputations
- • No lower limb braces
- • Not currently pregnant by self-report
- • Weight \<= 300 pounds
- Exclusion Criteria:
- • Severe head trauma or traumatic brain injury
- • History of seizures
- • Alternative neurologic illness or condition known to impact vestibular or balance function (e.g., stroke, neurodegenerative disorders, demyelinating illness)
- • Major psychiatric (e.g., panic disorder, psychosis, etc.) disorder
- • Any of the following eye diseases or conditions: amblyopia (or "lazy eye") or history of amblyopia, diagnosis of age- related macular degeneration, retina dystrophy, glaucoma, cataracts,
- • Recent (\<6 months) orthopedic injury to the lower extremities that may affect test performance
- • Upper extremity injuries requiring current sling immobilization
- • Recent surgery (\< 6 months) that may impact test performance.
- • Any other severe health problem (heart disease, pulmonary disease, cancer, etc.) that may affect test performance
- • Due to potentially nauseogenic nature of some motions and to protect fetus and mother, pregnant women will also be excluded from this study
- • Since we cannot address every possible potential individual recruit in advance, additional exclusion criteria may be required.
About Creighton University
Creighton University is a distinguished institution dedicated to advancing healthcare through innovative research and clinical trials. As a clinical trial sponsor, Creighton University leverages its robust academic resources and commitment to evidence-based practices to explore new treatment modalities and improve patient outcomes. The university's interdisciplinary approach fosters collaboration among healthcare professionals, researchers, and students, ensuring that clinical trials are conducted with the highest ethical standards and scientific rigor. By prioritizing participant safety and engagement, Creighton University aims to contribute significantly to the body of medical knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported